Modern Retina | Ophthalmology News, Events & Expert Insights
November 11th 2024. Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables detailed 3D visualization of choroidal vessels from OCT scans. This technique could improve diagnostics for retinal diseases like macular degeneration, offering a safer alternative to traditional methods.
Discovery of a common mechanistic defect and potential therapies …
Oct 8, 2024 · A new study 1 described the underlying defect responsible for development of age-related macular degeneration (AMD) and related macular dystrophies (MDs), such as Sorsby’s fundus dystrophy, Doyne honeycomb macular dystrophy, and autosomal dominant radial drusen.. The investigators, led by Sonal Dalvi, PhD, showed that reduced activity of matrix metalloproteinase 2 (MMPs) secreted from the ...
Distinction between lamellar holes and macular pseudoholes
Mar 12, 2018 · Dr. Thompson defined pseudomacular holes as a clinical diagnosis as seen via slit lamp biomicroscopy versus optical coherence tomography (OCT). “Use pseudomacular holes only to describe the biomicroscopic appearance,” he added. In contrast, a lamellar macular hole is defined by the appearance of the fovea via OCT.
Achromatopsia: Understanding the rare inherited retinal disease
Aug 27, 2018 · Achromatopsia is an autosomal recessive disease that affects approximately 1:30,000 individuals and is associated with complete loss of cone function. It is most commonly caused by mutations in the CNGB3 and CNGA3 genes and is associated with severely reduced visual acuity and extreme photosensitivity, resulting in daytime blindness.
Dealing with complications of silicone oil - Modern Retina
Sep 2, 2022 · Re-detachment after silicone oil removal is a major complication, with rates varying up to 30%. Suspected ERP and ERMs can be diagnosed by direct examination and OCT and removed when silicone oil is removed from the eye. Peripheral 360-degree laser retinopexy and scleral encircling band significantly diminish the rate of re-detachment.
EURETINA
EURETINA 2024: An overview of the SING-IMT implant with Alfonso Savastano, MD, PhD. Hattie Hayes; Martin David Harp. September 30th 2024. Alfonso Savastano, MD, PhD spoke about the SING-IMT implant during his interview with Ophthalmology Times Europe, which took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.
Patient-assistance programs for AMD treatments - Modern Retina
Feb 28, 2018 · Lucentis Access Solutions is another patient-assistance program from Genentech designed to provide patients with the medicine needed at a cost they can afford. Lucentis Access Solutions specialists can verify if a patient’s insurance covers AMD medication and determine out-of-pocket expenses. Specialists also can recommend patient-assistant ...
Belite Bio doses the first patient at the Tokyo Medical Center in the ...
Oct 9, 2024 · Belite Bio, Inc has dosed the first patient at the Tokyo Medical Center in the Phase 2/3 portion of the DRAGON II clinical trial evaluating Tinlarebant for the treatment of STGD1.
Diagnosing and treating MacTel degenerative retinal disease
Aug 1, 2017 · Later, Gass and Blodi identified three subtypes of the disease. 2 In 2006, Yannuzzi et al. proposed a classification that is commonly used: aneurysmal (type 1), perifoveal (type 2) and occlusive (type 3). 3 Type 1 appears to be a variant of Coats disease and type 3 is likely comprised of familial disorders with systemic associations. MacTel type 2 is the most common type and is the focus of ...
jCyte, Inc. announces pivotal trial of jCell for RP to start in second ...
Feb 24, 2024 · The pivotal trial of jCell to treat retinitis pigmentosa (RP) is scheduled to start enrollment during the second half of 2024. According to the company website, jCell is a first-in-class allogeneic cell therapy in late-stage clinical development for treating RP. The treatment is a minimally invasive intravitreal injection that can be performed ...